Pure Global

"Navellister" Fixi implantable infusion seat system - Taiwan Registration d8d4e54132df38a4888638bd3157b8db

Access comprehensive regulatory information for "Navellister" Fixi implantable infusion seat system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d8d4e54132df38a4888638bd3157b8db and manufactured by NAVILYST MEDICAL, INC.. The authorized representative in Taiwan is LORION ENTERPRISES INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d8d4e54132df38a4888638bd3157b8db
Registration Details
Taiwan FDA Registration: d8d4e54132df38a4888638bd3157b8db
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Navellister" Fixi implantable infusion seat system
TW: "ๅจœ็ถญๅˆฉๆ–ฏ็‰น"ๆ–ๅ…‹ๅธŒๆคๅ…ฅๅผ่ผธๆถฒๅบง็ณป็ตฑ
Risk Class 2
Cancelled

Registration Details

d8d4e54132df38a4888638bd3157b8db

DHA00601746302

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order

J General hospital and personal use equipment

J.5965 Subcutaneous implantable intravascular injection port and guide

import

Dates and Status

Dec 01, 2006

Dec 01, 2021

Oct 12, 2023

Cancellation Information

Logged out

ๆœชๅฑ•ๅปถ่€Œ้€พๆœŸ่€